JP4943128B2 - Powder-containing cosmetic - Google Patents
Powder-containing cosmetic Download PDFInfo
- Publication number
- JP4943128B2 JP4943128B2 JP2006332752A JP2006332752A JP4943128B2 JP 4943128 B2 JP4943128 B2 JP 4943128B2 JP 2006332752 A JP2006332752 A JP 2006332752A JP 2006332752 A JP2006332752 A JP 2006332752A JP 4943128 B2 JP4943128 B2 JP 4943128B2
- Authority
- JP
- Japan
- Prior art keywords
- powder
- silane
- cosmetic
- tridecafluorooctyl
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000843 powder Substances 0.000 title claims description 79
- 239000002537 cosmetic Substances 0.000 title claims description 46
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 51
- 229910000077 silane Inorganic materials 0.000 claims description 21
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 20
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 18
- 239000002131 composite material Substances 0.000 claims description 17
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 10
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 claims description 10
- 239000011248 coating agent Substances 0.000 claims description 10
- 238000000576 coating method Methods 0.000 claims description 10
- 239000010445 mica Substances 0.000 claims description 10
- 229910052618 mica group Inorganic materials 0.000 claims description 10
- 239000000377 silicon dioxide Substances 0.000 claims description 9
- AVYKQOAMZCAHRG-UHFFFAOYSA-N triethoxy(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane Chemical compound CCO[Si](OCC)(OCC)CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F AVYKQOAMZCAHRG-UHFFFAOYSA-N 0.000 claims description 7
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 5
- 238000004381 surface treatment Methods 0.000 claims description 5
- -1 perfluoroalkyl phosphate Chemical compound 0.000 description 38
- 230000000694 effects Effects 0.000 description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 12
- 229920001296 polysiloxane Polymers 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 239000004408 titanium dioxide Substances 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- 239000002552 dosage form Substances 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 229960005150 glycerol Drugs 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 239000006096 absorbing agent Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- RYXVKRMKSKSJRW-UHFFFAOYSA-N diethoxy-bis(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CC[Si](OCC)(CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)OCC RYXVKRMKSKSJRW-UHFFFAOYSA-N 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- 230000004807 localization Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229910044991 metal oxide Inorganic materials 0.000 description 5
- 150000004706 metal oxides Chemical class 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000006087 Silane Coupling Agent Substances 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000013065 commercial product Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001023 inorganic pigment Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000012756 surface treatment agent Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- BOZWETCMSXFTOW-UHFFFAOYSA-N 2-ethyl-2-(hydroxymethyl)propane-1,3-diol;16-methylheptadecanoic acid Chemical compound CCC(CO)(CO)CO.CC(C)CCCCCCCCCCCCCCC(O)=O BOZWETCMSXFTOW-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- FQCSIUSICFAMDD-UHFFFAOYSA-N 2-oxopyrrolidine-1-carboxylic acid;sodium Chemical compound [Na].OC(=O)N1CCCC1=O FQCSIUSICFAMDD-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- OXJGJKIURHREKH-UHFFFAOYSA-O CC(=C)C(=O)OCCP(=O)=C(O)C[N+](C)(C)C Chemical compound CC(=C)C(=O)OCCP(=O)=C(O)C[N+](C)(C)C OXJGJKIURHREKH-UHFFFAOYSA-O 0.000 description 1
- 241000723438 Cercidiphyllum japonicum Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241001251094 Formica Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- ZRMFNFGXKKFXKS-UHFFFAOYSA-N OCC(CO)(CO)CO.CCCCC Chemical compound OCC(CO)(CO)CO.CCCCC ZRMFNFGXKKFXKS-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 150000001343 alkyl silanes Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- SOGAXMICEFXMKE-UHFFFAOYSA-N alpha-Methyl-n-butyl acrylate Natural products CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- JBTHDAVBDKKSRW-UHFFFAOYSA-N chembl1552233 Chemical compound CC1=CC(C)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 JBTHDAVBDKKSRW-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 125000003709 fluoroalkyl group Chemical group 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- LDHBWEYLDHLIBQ-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide;hydrate Chemical compound O.[OH-].[O-2].[Fe+3] LDHBWEYLDHLIBQ-UHFFFAOYSA-M 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000004482 other powder Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229950004354 phosphorylcholine Drugs 0.000 description 1
- PYJNAPOPMIJKJZ-UHFFFAOYSA-N phosphorylcholine chloride Chemical compound [Cl-].C[N+](C)(C)CCOP(O)(O)=O PYJNAPOPMIJKJZ-UHFFFAOYSA-N 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 238000009700 powder processing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229940095050 propylene Drugs 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 238000006884 silylation reaction Methods 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000006104 solid solution Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- PDSVZUAJOIQXRK-UHFFFAOYSA-N trimethyl(octadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)C PDSVZUAJOIQXRK-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 150000003698 vitamin B derivatives Chemical class 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
化粧料に於いて、粉体は、その光学的効果によって、皮膚のシミ、そばかすなどの好ましくない色素の局在化などをカバーし、目立たなくさせる作用を有する。この為、この様な粉体含有化粧料に於いて、粉体の局在化はその本来の効果を著しく損なうものであり、これを防ぐことが粉体化粧料の最大の課題となっている。この様な粉体化粧料における粉体の局在化現象は、液体濡れの変化とともに「化粧崩れ」として捉えられている。この様な化粧崩れを防ぐ手段としては、「局在化抑制」、「液体濡れ抑制」においても、粉体の表面を種々の表面処理剤で被覆する方法が知られており、この様な被覆剤としては、ハイドロジェンメチルシロキサンの焼付、シランカップリング剤によるシリル化、パーフルオロアルキルリン酸塩による被覆、N−アシルグルタミン酸塩による被覆、リン脂質による被覆などが知られている。この内、パーフルオロアルキル基を有する表面処理剤による被覆は、撥水性と撥油性とを備えているために、汗による局在化も、皮脂による局在化もともに防げるため、化粧持ちの向上に有用な技術となっている。この様なパーフルオロ基を有する化合物を利用した技術としては、例えば、ペンタ−3,3,3−トリフルオロプロピルペンタメチルシクロペンタシロキサン等のパーフルオロアルキルシロキサンを利用した技術(例えば、特許文献1、特許文献2、特許文献3を参照)、パーフルオロアルキル基を有するリン酸エステル塩を利用した技術(例えば、特許文献4、特許文献5を参照)、パーフルオロアルキル・ポリオキシアルキレン共変性オルガノポリシロキサン(例えば、特許文献6を参照)、或いは、アルキルシランが炭素数6〜30のアルキル基を有し、パーフルオロアルキルシランのフルオロカーボン数が1〜30であるシランカップリング剤を用いた処理(例えば、特許文献7を参照)などが存する。しかしながら、この様なパーフルオロアルキル基を有する化合物による表面処理は時として、非処理のものと同様の化粧持ちしか発揮しない場合も存し、安定的に化粧持ちの良さが具現化できる技術の開発が望まれていた。この様な現象は、前記化粧料が肌との相互作用が弱いために、風や振動などの物理的な要因で脱落するためと考えられる。特に、フルオロアルキル基は摩擦係数を著しく軽減するために、皮膚との付着性が損なわれる場合が存した。一方、この様な粉体処理剤としてトリエトキシ(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロクチル)シラン、ジエトキシビス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロクチル)シラン又はエトキシトリス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロクチル)シランを用いた表面処理粉体は既に大東化成株式会社より販売されている。又、セリサイト又はマイカの表面を、シリカ、ジルコニア、チタニア及びアルミナから選択される粉体で被覆してなる複合化板状粉体も、化粧料原料として知られている(例えば、特許文献8、特許文献9、特許文献10を参照)。これらの複合化板状粉体は、板状粉体でありながら適度なカバー力を有し、しかも二酸化チタンや酸化亜鉛などのように室内の光源下で厚ぼったい、白っぽさを発現することもあまり無い優れた特性を有することが知られている。この様な化粧効果の唯一の欠点はその効果の持続性であった。しかしながら、一般式(I)で表されるパーフルオロアルキルシランで、複合化板状粉体の表面を処理してなる表面処理粉体も、この様な表面処理粉体を含有する化粧料も全く知られていない。更に、この様な表面処理粉体が、室内の光源下でも自然に見える演色効果を有し、且つ、この様な効果の持続性に優れることも全く知られていない。
(但し、式中nは2〜7の整数を表し、mは1〜3の整数を表し、aは1〜3の整数を表し、Rは炭素数1〜3のアルキル基を表す。)
In cosmetics, the powder has a function of covering undesired localization of pigments such as skin spots and freckles, etc., and making them inconspicuous due to its optical effect. For this reason, in such powder-containing cosmetics, the localization of the powder significantly impairs its original effect, and preventing it is the biggest challenge for powder cosmetics. . Such a powder localization phenomenon in powder cosmetics is regarded as “decoration of makeup” along with changes in liquid wetting. As a means for preventing such makeup breakage, methods for coating the surface of powder with various surface treatment agents are also known for “localization suppression” and “liquid wetting suppression”. As the agent, hydrogenmethylsiloxane baking, silylation with a silane coupling agent, coating with perfluoroalkyl phosphate, coating with N-acyl glutamate, coating with phospholipid, and the like are known. Among these, the coating with a surface treatment agent having a perfluoroalkyl group has both water and oil repellency, so it can prevent both localization due to sweat and sebum, thereby improving the durability of the makeup. It has become a useful technology . As a technique using such a compound having a perfluoro group, for example, a technique using a perfluoroalkylsiloxane such as penta-3,3,3-trifluoropropylpentamethylcyclopentasiloxane (for example, Patent Document 1). , Patent Document 2 and Patent Document 3), technology utilizing a phosphoric ester salt having a perfluoroalkyl group (for example, see Patent Document 4 and Patent Document 5), perfluoroalkyl / polyoxyalkylene co-modified organo Treatment using polysiloxane (for example, see Patent Document 6) or a silane coupling agent in which alkylsilane has an alkyl group having 6 to 30 carbon atoms and perfluoroalkylsilane has 1 to 30 fluorocarbons (See, for example, Patent Document 7). However, there are cases where surface treatment with such a compound having a perfluoroalkyl group sometimes exhibits only the same long-lasting makeup as that of the non-treated one, and the development of a technology that can stably realize the goodness of long-lasting makeup. Was desired. Such a phenomenon is thought to be due to the cosmetics falling off due to physical factors such as wind and vibration because the interaction with the skin is weak. In particular, the fluoroalkyl group significantly reduces the coefficient of friction, so that adhesion to the skin may be impaired. On the other hand, triethoxy (8, 8,8,7,7,6,6,5,5,4,4,3,3- Toridekafu Le Orokuchiru) as such powder processing agent silane, Jietokishibisu (8, 8, 8,7,7,6,6,5,5,4,4,3,3- Toridekafu Le Orokuchiru) silane or ethoxy tris (8, 8,8,7,7,6,6,5,5,4 , 4,3,3- Toridekafu Le Orokuchiru) silane surface-treated powder with the already available from Daito Kasei Corporation. Further, the surface of the sericite or mica, silica, zirconia, composite plate-like powder obtained by coating a powder selected from titania and alumina also that known as a cosmetic raw material (e.g., Patent Document 8 , See Patent Document 9 and Patent Document 10) . These composite plate-like powders have a suitable covering power while being plate-like powders, and also appear to be thick and whitish under indoor light sources such as titanium dioxide and zinc oxide. It is known to have excellent properties that are not so much. The only drawback of such a cosmetic effect was its persistence. However, perfluoroalkyl silane represented by the general formula (I), the front surface-treated powder ing to treat the surface of the composite plate-like powder also contains such surface-treated powder cosmetics Is not known at all. Further, such surface-treated powders has a color rendering effect that looks natural under room light sources, and, it is completely unknown also excellent in durability of such effects.
(In the formula, n represents an integer of 2 to 7, m represents an integer of 1 to 3, a represents an integer of 1 to 3, and R represents an alkyl group having 1 to 3 carbon atoms.)
本発明は、この様な状況下為されたものであり、室内の光源下で自然に見えるメークアップ化粧料であって、その効果持続性に優れるものを提供すること課題とする。 The present invention has been made under such circumstances, and an object of the present invention is to provide a makeup cosmetic that can be seen naturally under an indoor light source and that has excellent effect sustainability.
この様な状況に鑑みて、本発明者らは、室内の光源下で自然に見えるメークアップ化粧料であって、その効果持続性に優れるものを求めて、鋭意研究努力を重ねた結果、この様な効果を有する複合化板状粉体をトリエトキシ(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シラン、ジエトキシビス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シラン又はエトキシトリス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シランで表面処理することにより、その持続性を著しく向上できることを見いだ
し、発明を完成させるに至った。即ち、本発明は、以下に示すとおりである。
(1)トリエトキシ(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シラン、ジエトキシビス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シラン又はエトキシトリス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シランで、複合化板状粉体の表面を処理してなる、表面処理粉体。
(2)前記複合化板状粉体は、セリサイト又はマイカの表面を、シリカ、ジルコニア、チタニア及びアルミナから選択される粉体で被覆してなるものであることを特徴とする、(1)に記載の表面処理粉体。
(3)前記複合化板状粉体は、マイカチタニア、セリサイトチタニア又はシリカ・酸化鉄被覆セリサイトチタニアであることを特徴とする、(1)又は(2)に記載の表面処理粉体。
(4)(1)〜(3)の何れかに記載の表面処理粉体を含有してなる化粧料。
(5)室内光源用の化粧料であることを特徴とする、(1)〜(4)の何れかに記載の化粧料。
In view of such a situation, the present inventors have sought for a makeup cosmetic that looks natural under an indoor light source and has excellent effect sustainability. The composite plate-like powder having the above-mentioned effects is obtained by using triethoxy (8,8,8,7,7,6,6,5,5,4,4,3-tridecafluorooctyl) silane, diethoxybis (8 , 8,8,7,7,6,6,5,5,4,4,3,3-tridecafluorooctyl) silane or ethoxytris (8,8,8,7,7,6,6,5) , 5,4,4,3,3-tridecafluorooctyl) silane was found to be able to remarkably improve its sustainability, and the present invention was completed. That is, the present invention is as follows.
(1) Triethoxy (8,8,8,7,7,6,6,5,5,4,4,3,3-tridecafluorooctyl) silane, diethoxybis (8,8,8,7,7, 6,6,5,5,4,4,3,3-tridecafluorooctyl) silane or ethoxytris (8,8,8,7,7,6,6,5,5,4,4,3) A surface-treated powder obtained by treating the surface of a composite plate-like powder with 3-tridecafluorooctyl) silane .
(2) The composite plate-like powder is obtained by coating the surface of sericite or mica with a powder selected from silica, zirconia, titania and alumina. (1) The surface-treated powder described in 1.
(3) The surface-treated powder according to (1) or (2), wherein the composite plate-like powder is mica titania, sericite titania, or silica / iron oxide-coated sericite titania.
(4) A cosmetic comprising the surface-treated powder according to any one of (1) to (3).
(5) The cosmetic according to any one of (1) to (4), which is a cosmetic for an indoor light source.
本発明によれば、室内の光源下で自然に見えるメークアップ化粧料であって、その効果持続性に優れるものを提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, it is the makeup cosmetics which look natural under an indoor light source, Comprising: The thing excellent in the effect sustainability can be provided.
(1)本発明の表面処理粉体
本発明の表面処理粉体は、トリエトキシ(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シラン、ジエトキシビス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シラン又はエトキシトリス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シランで、複合化板状粉体の表面を処理してなることを特徴とする。前記複合化板状粉体とは、板状粉体を基体として、その表面に他の粉体成分、特に金属酸化物を被覆したもので、該被覆形態は焼成などを行い結晶格子のレベルで複合化することも可能であるし、メカノケミカル被覆のように、接触部分の一部が結合を共有する形態でも良い。前記板状粉体としては、セリサイト、マイカ、タルクなどが例示でき、これらの内では、セリサイト又はマイカが特に好ましい。更に被覆する粉体としては、珪酸カルシウム、珪酸マグネシウム、炭酸カルシウム、炭酸マグネシウム、シリカ、ジルコニア、チタニア及びアルミナから選択される1種乃至は2種以上が好ましく例示できる。この様な複合化板状粉体として好ましいものは、マイカチタニア、セリサイトチタニア又はシリカ・酸化鉄被覆セリサイトチタニアが好ましく例示できる。これらには既に市販品が存し、かかる市販品を購入して利用することが出来る。好ましい市販としては、マイカチタニアにはメルクGmbHの「チミロン」シリーズが例示でき、セリサイトチタニアには触媒化成工業株式会社から販売されている「カバーリーフ」シリーズが例示でき、シリカ・酸化鉄被覆セリサイトチタニアには触媒化成工業株式会社から販売されている「ダーマリアルリーフ」が例示できる。これらに、トリエトキシ(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シラン、ジエトキシビス(8,8,8,7,7,6,6
,5,5,4,4,3,3−トリデカフルオロオクチル)シラン又はエトキシトリス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シランを反応させ、シリル化することにより、本発明の表面処理粉体は製造される。
(1) Surface-treated powder of the present invention The surface-treated powder of the present invention is triethoxy (8,8,8,7,7,6,6,5,5,4,4,3,3-tridecafluoro). Octyl) silane, diethoxybis (8,8,8,7,7,6,6,5,5,4,4,3,3-tridecafluorooctyl) silane or ethoxytris (8,8,8,7, (7,6,6,5,5,4,4,3,3-tridecafluorooctyl) silane , which is obtained by treating the surface of the composite plate-like powder. The composite plate-like powder is a plate-like powder used as a base and the surface thereof is coated with other powder components, particularly a metal oxide. It is also possible to form a composite, or a form in which a part of the contact portion shares a bond like a mechanochemical coating may be used. Examples of the plate-like powder include sericite, mica, and talc. Among these, sericite or mica is particularly preferable. Further, as the powder to be coated, one or more kinds selected from calcium silicate, magnesium silicate, calcium carbonate, magnesium carbonate, silica, zirconia, titania and alumina can be preferably exemplified. Preferable examples of such a composite plate-like powder include mica titania, sericite titania, and silica / iron oxide-coated sericite titania. These already have commercial products, and such commercial products can be purchased and used. Examples of preferable commercially available products include the “Chimiron” series of Merck GmbH for mica titania, and the “cover leaf” series sold by Catalytic Chemical Industry Co., Ltd. for sericite titania. An example of cytotitania is “Derma Real Leaf” sold by Catalyst Kasei Kogyo Co., Ltd. These include triethoxy (8,8,8,7,7,6,6,5,5,4,4,3,3-tridecafluorooctyl) silane, diethoxybis (8,8,8,7,7, 6, 6
, 5,5,4,4,3,3-tridecafluorooctyl) silane or ethoxytris (8,8,8,7,7,6,6,5,5,4,4,3,3-tri) The surface-treated powder of the present invention is produced by reacting ( decafluorooctyl) silane and silylating.
この様に、粉体をトリエトキシ(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シラン、ジエトキシビス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シラン又はエトキシトリス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シランで処理するに際しては、通常のシランカップリング法に準じて行えば良く、例えば粉体を、溶剤などで希釈したトリエトキシ(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シラン、ジエトキシビス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シラン又はエトキシトリス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シランで被覆し、100〜300℃で所望により減圧しながら、焼付を行うことにより得ることが出来る。トリエトキシ(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シラン、ジエトキシビス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シラン又はエトキシトリス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シランには既に市販のものが存し、この様な市販品を購入して前記処理に付すことが出来る。この様な市販品としては、Dynasylan(商標)F8261(トリエトキシ(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロクチル)シラン)が好ましく例示できる。かかるシランカップリング剤である、トリエトキシ(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シラン、ジエトキシビス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シラン又はエトキシトリス(8,8,8,7,7,6,6,5,5,4,4,3,3−トリデカフルオロオクチル)シランは唯一種を表面処理に用いることも出来るし、二種以上を組み合わせて用いることも出来る。好ましい粉体とパーフルオロアルキルシランとの量比は1:99〜30:70であり、より好ましくは2:98〜10:90である。かかるパーフルオロアルキルシランを適当な溶剤、例えばクロロホルムや塩化メチレンなどで1〜100倍量を加え一様にコートした後、加熱処理、脱アルコール反応を行い、シランカップリングを行えばよい。この様な過程を経て作製された本発明の表面処理粉体は、基体となっている複合化板状粉体の、室内の光源下で自然に見えるカバー力を発現させると言う、類い希な光学的特性を損なうことなく、その化粧効果の持続性に優れる。特に、撥水・撥油性を有するが故に、肌との密着性に難を有し、物理的な応力により、肌より脱落しやすいという、パーフルオロアルキルシラン処理粉体の欠点を克服し、撥水・撥油性を維持しながら、肌との密着性にも優れる特性を有する。この様に、化粧料における、光学効果の中心的役割を演じる複合化板状粉体の化粧持ちを向上せしめることにより、化粧料全体の化粧持ちも著しく向上する。 In this manner, the powder was triethoxy (8,8,8,7,7,6,6,5,5,4,4,3,3-tridecafluorooctyl) silane, diethoxybis (8,8,8, 7,7,6,6,5,5,4,4,3,3-tridecafluorooctyl) silane or ethoxytris (8,8,8,7,7,6,6,5,5,4) When treating with 4,3,3-tridecafluorooctyl) silane , it may be carried out in accordance with a normal silane coupling method. For example, triethoxy (8,8,8,7 ) obtained by diluting a powder with a solvent or the like. , 7,6,6,5,5,4,4,3,3-tridecafluorooctyl) silane, diethoxybis (8,8,8,7,7,6,6,5,5,4,4) 3,3-tridecafluorooctyl) silane or ethoxytris (8,8,8,7,7,6,6) 5,5,4,4,3,3- coated with tridecafluorooctyl) silane, while reducing the pressure desired at 100 to 300 ° C., it can be obtained by performing the baking. Triethoxy (8,8,8,7,7,6,6,5,5,4,4,3,3-tridecafluorooctyl) silane, diethoxybis (8,8,8,7,7,6,6) , 5,5,4,4,3,3-tridecafluorooctyl) silane or ethoxytris (8,8,8,7,7,6,6,5,5,4,4,3,3-tri) Decafluorooctyl) silane already exists on the market, and such a commercial product can be purchased and subjected to the treatment. As such a commercial product, Dynasylan (trademark) F8261 (triethoxy (8,8,8,7,7,6,6,5,5,4,4,3,3-tridecafluorooctyl) silane) is available. Preferred examples can be given. Such silane coupling agents are triethoxy (8,8,8,7,7,6,6,5,5,4,4,3,3-tridecafluorooctyl) silane, diethoxybis (8,8,8). , 7,7,6,6,5,5,4,4,3,3-tridecafluorooctyl) silane or ethoxytris (8,8,8,7,7,6,6,5,5,4) , 4,3,3-tridecafluorooctyl) silane can be used alone for the surface treatment or in combination of two or more. The amount ratio of the preferable powder and perfluoroalkylsilane is 1:99 to 30:70, more preferably 2:98 to 10:90. After the perfluoroalkylsilane is uniformly coated with an appropriate solvent, for example, chloroform or methylene chloride, in an amount of 1 to 100 times, silane coupling may be performed by heat treatment and dealcoholization reaction. The surface-treated powder of the present invention produced through such a process is said to exhibit a covering power of the composite plate-like powder serving as a base that can be seen naturally under an indoor light source. It is excellent in the sustainability of its cosmetic effect without impairing its optical properties. In particular, because of its water and oil repellency, it overcomes the disadvantages of perfluoroalkylsilane-treated powders that have difficulty in adhesion to the skin, and is easily removed from the skin due to physical stress. While maintaining water and oil repellency, it has excellent adhesion to the skin. In this way, by improving the makeup of the composite plate-like powder that plays the central role of the optical effect in the cosmetic, the cosmetic durability of the entire cosmetic is significantly improved.
(2)本発明の化粧料
本発明の化粧料は、前記必須成分を含有することを特徴とする。本発明の化粧料としては、通常粉体を含有することの出来る剤形のものであれば特段の限定無く、応用できる。好ましい剤形を例示すれば、例えば、油中水乳化剤形、水中油乳化剤形、オイルゲル剤形、固形粉体剤形、ルースパウダー剤形等が例示できる。特に好ましいものは、水を含有しない剤形で、且つ、油性成分の含有量が15質量%以下のものであり、具体的には、固形粉体剤形である。この形態が表面処理の長所を特に生かせるためである。
(2) Cosmetics of this invention The cosmetics of this invention contain the said essential component, It is characterized by the above-mentioned. The cosmetic of the present invention can be applied without particular limitation as long as it is in a dosage form that can usually contain powder. Examples of preferable dosage forms include water-in-oil emulsifier forms, oil-in-water emulsifier forms, oil gel dosage forms, solid powder dosage forms, and loose powder dosage forms. Particularly preferred is a dosage form that does not contain water and has an oil component content of 15% by mass or less, specifically a solid powder dosage form. This is because this form makes the most of the advantages of surface treatment.
本発明の化粧料は、前記の必須成分以外に、通常化粧料で使用される任意成分を含有することが出来る。この様な任意成分としては、例えば、マカデミアナッツ油、アボカド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類、流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類、オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類、セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等、イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類、ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン、アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類、脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類、塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類、イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等の両性界面活性剤類、ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類、ポリエチレングリコール、グリセリン、1,3−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオ
ール、2,4−ヘキサンジオール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類、ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類、表面を処理されていても良い、マイカ、タルク、カオリン、合成雲母、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸(シリカ)、酸化アルミニウム、硫酸バリウム等の粉体類、表面を処理されていても良い、ベンガラ、黄酸化鉄、黒酸化鉄、酸化コバルト、群青、紺青、酸化チタン、酸化亜鉛の無機顔料類或いはこれら無機顔料の複合体、表面を処理されていても良い、雲母チタン、魚燐箔、オキシ塩化ビスマス等のパール剤類、レーキ化されていても良い赤色202号、赤色228号、赤色226号、黄色4号、青色404号、黄色5号、赤色505号、赤色230号、赤色223号、橙色201号、赤色213号、黄色204号、黄色203号、青色1号、緑色201号、紫色201号、赤色204号等の有機色素類、ポリエチレン末、ポリメタクリル酸メチル、ナイロン粉末、オルガノポリシロキサンエラストマー等の有機粉体類、パラアミノ安息香酸系紫外線吸収剤、アントラニル酸系紫外線吸収剤、サリチル酸系紫外線吸収剤、桂皮酸系紫外線吸収剤、ベンゾフェノン系紫外線吸収剤、糖系紫外線吸収剤、2−(2’−ヒドロキシ−5’−t−オクチルフェニル)ベンゾトリアゾール、4−メトキシ−4’−t−ブチルジベンゾイルメタン等の紫外線吸収剤類、エタノール、イソプロパノール等の低級アルコール類;ビタミンA又はその誘導体、ビタミンB 6 塩酸塩、ビタミンB 6 トリパルミテート、ビタミンB 6 ジオクタノエート、ビタミンB 2 又はその誘導体、ビタミンB 12 、ビタミンB 15 又はその誘導体等のビタミンB類、α−トコフェロール、β−トコフェロール、γ−トコフェロール、ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類等、フェノキシエタノール等の抗菌剤などが好ましく例示できる。これらの内で特に好ましいものは、アクリル酸乃至はメタクリル酸と2−ホスホリルコリニルエタノールとのエステルを構成モノマーとする、ポリマー乃至はコポリマーで被覆した粉体が例示できる。この様なポリマー乃至はコポリマーには既に市販品が存し、かかる市販品を購入し、粉体に被覆して用いることが出来る。この様な市販品としては、日本油脂株式会社から販売されている、「リピジュアHM」(ポリメタクリロイルオキシエチルホスホリルコリン)、「リピジュアPBS」(メタクリロイルオキシエチルホスホリルコリン・ブチルメタクリレートコポリマー)等が好適に例示できる。又、表面処理される粉体としては、タルクが好ましい。タルクと前記ポリマー乃至はコポリマーの質量比は99:1〜70:30が好ましく、より好ましくは98:2〜90:10である。被覆処理は、粉体にポリマー乃至はコポリマーの水溶液を噴霧し、乾燥させることにより製造できる。かかる粉体の好ましい含有量は0.1〜10質量%であり、より好ましくは0.5〜5質量%である。この量比に於いて前記パーフルオロアルキルシラン表面処理粉体の皮膚への密着性を向上させることが出来る。
The cosmetics of this invention can contain the arbitrary components normally used with cosmetics other than the said essential component. Examples of such optional components, e.g., macadamia nut oil, Abou transient oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, cured Oils such as coconut oil, hydrogenated oil, owl, hydrogenated castor oil, beeswax, candelilla wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba wax, waxes , liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin , petrolatum, hydrocarbons such as microcrystalline wax, oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, higher fatty acids such as undecylenic acid, cetyl alcohol, stearyl alcohol, Isosuteari Alcohol, behenyl alcohol, octyldodecanol, myristyl alcohol, higher alcohols such as cetostearyl alcohol, cetyl isooctanoate, isopropyl myristate, isostearate hexyl decyl, diisopropyl adipate, sebacic di-2-ethylhexyl, cetyl lactate, malate Diisostearyl, di-2-ethylhexanoic acid ethylene glycol, dicaprate neopentyl glycol, di-2-heptylundecanoic acid glycerin, tri-2-ethylhexanoic acid glycerin, tri-2-ethylhexanoic acid trimethylolpropane, tri isostearate trimethylolpropane, synthetic ester oils such as tetra-2-ethylhexanoate pentane pentaerythritol, dimethyl polysiloxane, methylphenyl Rokisan, linear polysiloxanes such as diphenyl polysiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, cyclic polysiloxanes such as dodeca methylcyclohexane siloxane, amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxanes, oil such silicone oils of modified polysiloxanes and fluorine-modified polysiloxane, fatty acid soap (sodium laurate, sodium palmitate), potassium lauryl sulfate, an anionic surfactant such as alkyl sulfate, triethanolamine ether, chloride Cationic surfactants such as stearyltrimethylammonium, benzalkonium chloride, laurylamine oxide , imidazoline-based amphoteric surfactants (2-cocoyl-2-imida Zolinium hydroxide-1-carboxyethyloxy disodium salt, etc.), betaine surfactants (alkyl betaine, amide betaine, sulfobetaine, etc.), amphoteric surfactants such as acylmethyltaurine , sorbitan fatty acid esters (sorbitan) Monostearate, sorbitan sesquioleate, etc.), glycerin fatty acids (eg, glyceryl monostearate), propylene glycol fatty acid esters (eg, propylene glycol monostearate), hardened castor oil derivatives, glycerin alkyl ethers, POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene sorbitan monostearate, etc.), POE sorbite fatty acid esters (POE-sorbitol monolaurate, etc.), POE glycerin fatty acid ester Tells (POE-glycerol monoisostearate, etc.), POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyldodecyl ether, etc.), POE alkylphenyl ethers (POE nonylphenyl) Ethers, etc.), Pluronic types, POE / POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), Tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), sucrose fatty acid esters, nonionic surfactants, polyethylene glycols such as alkyl glucoside, glycerine, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene Recall, dipropylene glycol, diglycerin, isoprene glycol, 1,2-pentanediol, 2,4-hexanediol, 1,2-hexanediol, polyhydric alcohols such as 1,2-octanediol, sodium pyrrolidone carboxylic acid Moisturizing ingredients such as lactic acid and sodium lactate, surface may be treated , powder such as mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, anhydrous silicic acid (silica), aluminum oxide, barium sulfate body such, may be processed to the front surface, red iron oxide, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, iron blue, titanium oxide, inorganic pigments, or complexes of these inorganic pigments zinc oxide, a surface treatment may be, mica titanium, Sakanarinhaku, pearl agent such as bismuth oxychloride, is laking Red 202, Red 228, Red 226, Yellow 4, Blue 404, Yellow 5, Red 505, Red 230, Red 223, Orange 201, Red 213, Yellow 204 Organic dyes such as yellow 203, blue 1, green 201, purple 201, red 204 , polyethylene powder, polymethyl methacrylate, nylon powder, organopolysiloxane elastomer , para-aminobenzoic acid acid UV absorbers, anthranilic acid UV absorbers, salicylic acid ultraviolet absorbers, Katsura peel acid UV absorbers, Baie benzophenone-based ultraviolet absorbents, sugar-based ultraviolet absorber, 2- (2'-hydroxy-5 ' -t- octylphenyl) benzotriazole, 4-methoxy-4'-t-butyl-dibenzo yl ultraviolet absorbers such as methane, ethanol, iso Lower alcohols such propanol; vitamin A or a derivative thereof, vitamin B 6 hydrochloride, vitamin B 6 tripalmitate, vitamin B 6 dioctanoate, vitamin B 2 or derivatives thereof, vitamin B 12, such as vitamin B 15 or a derivative thereof Vitamin B , α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E such as vitamin E acetate, vitamin D, vitamin H, vitamins such as pantothenic acid, panthetin, pyrroloquinoline quinone , etc., antibacterial such as phenoxyethanol An agent etc. can be illustrated preferably. Particularly preferable among these are powders coated with a polymer or a copolymer containing acrylic acid or an ester of methacrylic acid and 2-phosphorylcorinylethanol as a constituent monomer. Such a polymer or copolymer already has a commercially available product, and such a commercially available product can be purchased and coated with powder. Examples of such commercially available products include “Lipidure HM” (polymethacryloyloxyethyl phosphorylcholine), “Lipidure PBS” (methacryloyloxyethyl phosphorylcholine / butyl methacrylate copolymer) and the like sold by Nippon Oil & Fat Co., Ltd. . Further, talc is preferable as the surface-treated powder. The mass ratio of talc to the polymer or copolymer is preferably 99: 1 to 70:30, more preferably 98: 2 to 90:10. The coating treatment can be produced by spraying an aqueous solution of a polymer or copolymer onto the powder and drying it. The preferable content of such powder is 0.1 to 10% by mass, and more preferably 0.5 to 5% by mass. In this amount ratio, the adhesion of the perfluoroalkylsilane surface-treated powder to the skin can be improved.
又、本発明の処理粉体の光学効果と対極の「厚ぼったく隠蔽する」光学効果を有する、二酸化チタンや酸化亜鉛については、他の金属酸化物と複合化することにより、その光学効果を減じておくことが好ましい。かかる成分を構成する他の金属としては、鉄、珪素、亜鉛、ジルコニウム、アルミニウムなどが好適に例示できる。複合化の形態は、他の金属酸化物を二酸化チタンの結晶格子中に押し込めたドープ形態、他の金属酸化物の微粉末と、二酸化チタンの微粉末とを500〜1000℃で焼いて、固めた焼成形態、二酸化チタンの表面に金属酸化物乃至は水酸化物を沈積させ、これを1000℃以上の温度で溶融させて二酸化チタンと相溶させ、冷却固化させた固溶体形態などが存する。これらの何れもが使用可能である。これらの粉体は、斯くの如くに製造することも出来るが、市販品を購入して利用することも出来る。好ましい市販品としては、三重顔料株式会社製の「イエロ
ーチタン」(酸化鉄・二酸化チタン焼結顔料)、石原産業株式会社製の「タイペークTTO−F1」、「タイペークTTO−F2」、「タイペークTTO−F6」(二酸化チタンの表面にシリカ、アルミナ、ジルコニアを固溶体化したもの)等が好ましく例示できる。これらの粉体は表面をハイドロジェンメチルポリシロキサン、レシチン、N−アシルグルタミン酸塩、ポリエチレン、金属石鹸などで被覆されていても良い。これらの粉体は紫外線からの隠蔽力は二酸化チタンそのものには若干劣るが、紫外線を吸収後ラジカルの発生が極めて抑制されているので、総合的な紫外線からの防護効果は非常に優れている。かかる粉体は、厚ぼったさを感じさせずに、隠蔽力効果を発現する量を含有することが好ましく、具体的には、5〜30質量%含有することが好ましく、7〜25質量%含有することがより好ましい。
In addition, for titanium dioxide and zinc oxide, which have the optical effect of the treated powder of the present invention and the optical effect of concealing “thickly”, the optical effect is reduced by compounding with other metal oxides. It is preferable to keep it. Examples of other metals constituting such components include iron, silicon, zinc, zirconium, aluminum and the like. The composite form is a dope form in which another metal oxide is pressed into the crystal lattice of titanium dioxide, and the fine powder of the other metal oxide and the fine powder of titanium dioxide are baked at 500 to 1000 ° C. and hardened. There is a solid solution form in which a metal oxide or hydroxide is deposited on the surface of titanium dioxide, melted at a temperature of 1000 ° C. or more and dissolved with titanium dioxide, and solidified by cooling. Any of these can be used. These powders can be produced as described above, but commercially available products can also be purchased and used. Preferred commercially available products include “Yellow Titanium” (iron oxide / titanium dioxide sintered pigment) manufactured by Mie Pigment Co., Ltd., “Taipaque TTO-F1”, “Taipaque TTO-F2”, and “Taipaque TTO” manufactured by Ishihara Sangyo Co., Ltd. -F6 "(one obtained by solidifying silica, alumina, or zirconia on the surface of titanium dioxide) is preferred. The surface of these powders may be coated with hydrogen methyl polysiloxane, lecithin, N-acyl glutamate, polyethylene, metal soap, and the like. These powders are slightly inferior to titanium dioxide itself in hiding power from ultraviolet rays, but since radical generation is extremely suppressed after absorbing ultraviolet rays, the overall protective effect against ultraviolet rays is very good. Such a powder preferably contains an amount that exhibits a hiding power effect without feeling thick, and specifically, it is preferably contained in an amount of 5 to 30% by mass, and 7 to 25% by mass. It is more preferable to contain.
これら必須成分、任意成分を常法に従って処理することにより、本発明の化粧料は製造することが出来る。 The cosmetic of the present invention can be produced by treating these essential components and optional components according to a conventional method.
以下に、本発明の化粧料について、実施例を挙げて、更に詳細に説明を加えるが、本発明がかかる実施例にのみ限定されないことは言うまでもない。 Hereinafter, examples of the cosmetic of the present invention will be described in more detail, but it goes without saying that the present invention is not limited to such examples.
<製造例1>
「チミロンMP1005」96質量部に、1質量部のトリエチルアミンを100質量部のエタノールに溶解した溶液を噴霧し、40℃で2時間送風乾燥した後、4質量部の「DynasylanF8261」を200質量部の塩化メチレンに溶解したものを噴霧し、100℃に熱した電気炉に入れ、電気炉の温度を5時間かけて200℃まで昇温し、200℃で2時間保持した後、8時間かけて室温まで降温して、本発明の表面処理粉体1を得た。
<Production Example 1>
A solution of 1 part by weight of triethylamine dissolved in 100 parts by weight of ethanol was sprayed on 96 parts by weight of “Timilon MP1005”, air-dried at 40 ° C. for 2 hours, and then 4 parts by weight of “Dynasylan F8261” was added to 200 parts by weight. A solution dissolved in methylene chloride is sprayed, put in an electric furnace heated to 100 ° C., heated to 200 ° C. over 5 hours, held at 200 ° C. for 2 hours, and then room temperature over 8 hours. The surface-treated powder 1 of the present invention was obtained.
<製造例2>
製造例1の「チミロンMP1005」を「ダーマリアルリーフN」に置換して、同様に処置し、本発明の表面処理粉体2を得た。
<Production Example 2>
The “Timilon MP1005” in Production Example 1 was replaced with “Derma Real Leaf N” and treated in the same manner to obtain the surface-treated powder 2 of the present invention.
<製造例3>
製造例1の「チミロンMP1005」を「カバーリーフPC−1035」(チタンセリサイト)に置換して、同様に処置し、本発明の表面処理粉体3を得た。
<Production Example 3>
The “Timiron MP1005” in Production Example 1 was replaced with “Coverleaf PC-1035” (titanium sericite) and treated in the same manner to obtain the surface-treated powder 3 of the present invention.
以下に示す表1の処方に従って、本発明の化粧料である固形粉体化粧料(夏用ファンデーション)を製造した。即ち、イの成分をヘンシェルミキサーに秤込み、混合攪拌した後、0.9mm丸穴スクリーンを装着したパルベライザーで粉砕し、ヘンシェルミキサーに戻し、混合しながら、ロの成分を噴霧し、コーティングを行い、1mmヘリングボーンスクリーンを装着したパルベライザーで粉砕し、粉砕物を金皿に詰め、加圧成形して固形粉体化粧料1を得た。同様に操作して、表面処理粉体1を「チミロンMP1005」に置換した比較例1、3%ハイドロジェンメチルポリシロキサン焼付処理(以後、単にシリコーン処理と称すこともある)「チミロンMP1005」に置換した比較例2、パーフルオロアルキルリン酸ジエタノールアミン塩3%被覆した「チミロンMP1005」に置換した比較例3及び二酸化チタンに置換した比較例4を作製した。 A solid powder cosmetic (summer foundation), which is a cosmetic of the present invention, was produced according to the formulation shown in Table 1 below. In other words, after the ingredients of A were weighed into a Henschel mixer, mixed and stirred, pulverized with a pulverizer equipped with a 0.9mm round hole screen, returned to the Henschel mixer, and mixed while spraying the ingredients of B. The solid powder cosmetic 1 was obtained by pulverizing with a pulverizer equipped with a 1 mm herringbone screen, filling the pulverized material in a metal pan, and press molding. In the same manner, Comparative Example 1 in which the surface-treated powder 1 was replaced with “Timilon MP1005”, and 3% hydrogen methylpolysiloxane baking treatment (hereinafter sometimes simply referred to as “silicone treatment”) was replaced with “Thimilon MP1005”. Comparative Example 2, Comparative Example 3 substituted with “Thimilon MP1005” coated with 3% perfluoroalkyl phosphate diethanolamine salt and Comparative Example 4 substituted with titanium dioxide were produced.
<試験例1>
専門パネラー3名を用いて、固形粉体化粧料1、比較例1〜4について、「化粧仕上がりの自然さ」と「カバー力」と「化粧持ち」について、実使用条件下での比較評価を行った。テスト期間は1ヶ月設け、それぞれの化粧料をテスト期間中に少なくとも3回は実使用してもらい、必要があれば、再度使用してもらい、下記に示す基準のスコアで評価してもらった。結果を例数として表2に示す。本発明の表面処理粉体を含有する本発明の化粧料のメークアップ効果が優れるものであることは全てのパネラーの認めるところであった。
(スコアの基準)
スコア1:ものたりない
スコア2:ややものたりない
スコア3:可もなく不可もなく
スコア4:やや優れる
スコア5:優れる
<Test Example 1>
Using three professional panelists, for the solid powder cosmetics 1 and Comparative Examples 1 to 4, “Naturalness of makeup finish”, “Cover power” and “Long makeup” were evaluated under actual use conditions. went. The test period was set for one month, and each cosmetic was actually used at least three times during the test period. If necessary, the cosmetics were used again and evaluated according to the standard scores shown below. The results are shown in Table 2 as the number of examples. All panelists recognized that the cosmetics of the present invention containing the surface-treated powder of the present invention have an excellent make-up effect.
(Score criteria)
Score 1: Unsatisfactory score 2: Slightly unsatisfactory score 3: Slightly unacceptable Score 4: Slightly excellent score 5: Excellent
<試験例2>
試験例1の効果を数値として確認するため、上腕内側部に設けた2cm×4cmの部位に40mgの化粧料を塗布し、グロスメータでグロス値(G値)を計測し、自然にそのまま3時間過ごした後、再度G値を計測した。結果を表3に示す。これより、本発明の化粧料はG値の経時変化が少なく、自然な、つややかなツヤが長時間継続することがわかる。
<Test Example 2>
To confirm the effect of the Test Example 1 as the number value, by applying the cosmetic composition of 40mg to the site of 2 cm × 4 cm provided on the upper inner arm portion, measured gloss values (G value) in the grayed b Sumeta, naturally it After 3 hours, the G value was measured again. The results are shown in Table 3. From this, it can be seen that the cosmetic of the present invention has little change in G value with time, and natural and glossy gloss lasts for a long time.
実施例1と同様に下記の処方に従って、本発明の化粧料である固形粉体化粧料2を製造した。このものの専門パネラー1名による試験例1の評価は、「化粧仕上がりの自然さ」、「カバー力」、「化粧持ち」全てに於いてスコア5であり、試験例2のG値の変化は6.4→6.3であり、実施例1の化粧料と同様の効果を有していることがわかる。 In the same manner as in Example 1, a solid powder cosmetic 2 as a cosmetic of the present invention was produced according to the following formulation. The evaluation of Test Example 1 by one expert panelist is score 5 in all of “naturalness of makeup finish”, “covering power”, and “holding makeup”, and the change in G value of Test Example 2 is 6 .4 → is 6.3, it is found to have the same effect as cosmetic of example 1.
実施例1と同様に下記の表5の処方に従って、本発明の化粧料である固形粉体化粧料3を製造した。このものの専門パネラー1名による試験例1の評価は、「化粧仕上がりの自然さ」、「カバー力」、「化粧持ち」全てに於いてスコア5であり、試験例2のG値の変化は5.1→4.8であり、実施例1の化粧料と同様の効果を有していることがわかる。 In the same manner as in Example 1, a solid powder cosmetic 3 as a cosmetic of the present invention was produced according to the formulation shown in Table 5 below. The evaluation of Test Example 1 by one expert panelist is score 5 in all of “naturalness of makeup finish”, “covering power”, and “long makeup”, and the change in G value of Test Example 2 is 5 .1 → 4.8, it is found to have the same effect as cosmetic of example 1.
本発明は、自然な仕上がりで、化粧持ちに優れる化粧料に応用できる。 INDUSTRIAL APPLICABILITY The present invention can be applied to cosmetics having a natural finish and excellent makeup lasting.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006332752A JP4943128B2 (en) | 2006-12-11 | 2006-12-11 | Powder-containing cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006332752A JP4943128B2 (en) | 2006-12-11 | 2006-12-11 | Powder-containing cosmetic |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2008143837A JP2008143837A (en) | 2008-06-26 |
JP2008143837A5 JP2008143837A5 (en) | 2010-01-14 |
JP4943128B2 true JP4943128B2 (en) | 2012-05-30 |
Family
ID=39604410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006332752A Active JP4943128B2 (en) | 2006-12-11 | 2006-12-11 | Powder-containing cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4943128B2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5587548B2 (en) * | 2008-10-17 | 2014-09-10 | 株式会社コーセー | Water-based solid cosmetic |
JP2010095501A (en) * | 2008-10-20 | 2010-04-30 | Kose Corp | Water-containing powder makeup cosmetic material |
JP5679502B2 (en) * | 2012-02-28 | 2015-03-04 | 花王株式会社 | Cosmetics |
CN104220044B (en) * | 2012-02-28 | 2017-05-31 | 花王株式会社 | Cosmetics |
WO2013129328A1 (en) * | 2012-02-28 | 2013-09-06 | 花王株式会社 | Cosmetic |
JP5956837B2 (en) * | 2012-06-11 | 2016-07-27 | 花王株式会社 | Water-in-oil emulsified cosmetic |
JP6453672B2 (en) * | 2015-03-02 | 2019-01-16 | 花王株式会社 | Water-in-oil emulsified cosmetic |
JP6452495B2 (en) * | 2015-03-02 | 2019-01-16 | 花王株式会社 | Water-in-oil emulsified cosmetic |
JP6452496B2 (en) * | 2015-03-02 | 2019-01-16 | 花王株式会社 | Water-in-oil emulsified cosmetic |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02218603A (en) * | 1989-02-21 | 1990-08-31 | Shiseido Co Ltd | Cosmetic |
JPH06192594A (en) * | 1992-01-29 | 1994-07-12 | Teika Corp | Water-repellent and oil-repellent pigment and powdery cosmetic containing the same |
JP3043903B2 (en) * | 1992-06-29 | 2000-05-22 | ポーラ化成工業株式会社 | Powder cosmetics |
JPH0859427A (en) * | 1994-08-12 | 1996-03-05 | Shiseido Co Ltd | Cosmetic |
JP3566050B2 (en) * | 1997-10-22 | 2004-09-15 | ポーラ化成工業株式会社 | External preparation for skin |
JPH11130630A (en) * | 1997-10-24 | 1999-05-18 | Pola Chem Ind Inc | Evaluation of messy makeup |
JPH11217315A (en) * | 1998-01-27 | 1999-08-10 | Pola Chem Ind Inc | Makeup cosmetic showing natural appearance |
EP1066818B1 (en) * | 1998-04-01 | 2011-02-09 | JGC Catalysts and Chemicals Ltd. | Inorganic composite powder and cosmetic comprising the same |
JP3953188B2 (en) * | 1998-04-28 | 2007-08-08 | ポーラ化成工業株式会社 | Makeup cosmetics with optical effect |
JPH11310517A (en) * | 1998-04-28 | 1999-11-09 | Pola Chem Ind Inc | Water-and oil-repellent makeup cosmetic |
JPH11349444A (en) * | 1998-06-10 | 1999-12-21 | Pola Chem Ind Inc | Make-up cosmetic difficult to get messy |
US6315990B1 (en) * | 1999-12-20 | 2001-11-13 | Avon Products, Inc. | Cosmetic composition having fluorosilane coated particulates |
-
2006
- 2006-12-11 JP JP2006332752A patent/JP4943128B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2008143837A (en) | 2008-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4943128B2 (en) | Powder-containing cosmetic | |
JP2008143837A5 (en) | ||
JP5184031B2 (en) | Emulsifier-type powder-containing external skin preparation | |
JP4874077B2 (en) | Surface-treated powder and cosmetics containing the surface-treated powder | |
JP2016124846A (en) | Powder cosmetics | |
JP2008143836A5 (en) | ||
JP2008297238A (en) | Water-in-oil emulsion type powder-containing external preparation for skin | |
JP2007320906A (en) | Fine wrinkle improver | |
JP2008137944A (en) | Powdery material for cosmetic and cosmetic containing the same | |
JP4880078B1 (en) | Powder cosmetics | |
JP5340588B2 (en) | Cosmetics for correcting pores | |
JP2010126445A (en) | Solid powder cosmetic | |
JP6305230B2 (en) | Stick-like body odor control composition | |
JP6644416B2 (en) | Composition for suppressing body odor | |
JP2009155211A5 (en) | ||
JP4920216B2 (en) | Solid cosmetics | |
JP2006335641A (en) | Cosmetic comprising powder | |
JP2008297240A (en) | Solid powder cosmetic | |
JP5491742B2 (en) | Makeup cosmetics | |
JP5133119B2 (en) | Cosmetic powder | |
JP2010248100A (en) | Lip cosmetic | |
JP2010248100A5 (en) | ||
JP2019112330A (en) | Emulsion cosmetic | |
JP5653401B2 (en) | Method for producing powder-containing external preparation for skin containing emulsifier | |
JP4991166B2 (en) | Cosmetic for decollete |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091124 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20091124 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20091124 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110809 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110816 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20111013 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20111018 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111101 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120131 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120229 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20180309 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |